TokenPost·
iRhythm Raises 2026 Revenue Outlook and Expects 2027 Zio MCT FDA Filing
Third-quarter revenue was $221.6 million, up nearly 15% from a year earlier. iRhythm expects Zio AT revenue to decline about 10% in the fourth quarter.
More news
- TokenPostRobinhood Executives Sell 14,473 Shares Worth About $1.23 Million
- TokenPost159 Hyperliquid Addresses Add $43.17 Million in Net Longs Across 27 Instruments
- TokenPostChainalysis Says Attack Exposed Password Hashes and Active Tokens
- CryptoSlateThailand is cutting off Bitget. Users have until December 5 to prepare
- NewsBTCNigeria Sets New Stablecoin Licensing Rules and Capital Requirements
- TokenPostCoinbase Bitcoin Order Book Shows $15.70 Million Bid Surplus in Nov. 6 Snapshot